Eli Lilly and Company

LLYEli Lilly and Company

About Eli Lilly and Company

Eli Lilly (NYSE:LLY) is a global healthcare leader that specializes in creating high-quality medicines for multiple therapeutic areas. Engaging in comprehensive drug discovery to drive innovation, the company organizes its operations across human pharmaceutical products and animal health products divisions. Its projects primarily involve research, development, manufacturing and marketing operations. The company aims to offer successful medical breakthroughs, addressing severe health challenges, and assisting healthcare professionals in providing better treatments globally. Eli Lilly’s objectives include saving and improving lives, enhancing shareholder value through business growth and sustainability.

What is LLY known for?

Snapshot

Public US

Ownership

1876

Year founded

42001

Employees

Indianapolis, United States

Head office

Loading Map...

Operations

All Locations

Indianapolis, US

Products and/or services of Eli Lilly and Company

Insulin Glargine injection, an advanced insulin therapy, stands as a milestone in a patient's disease management journey.
Taltz, a revolutionary plaque psoriasis treatment provides a beacon of hope for those seeking better skin health.
Cyramza, a targeted therapy for stomach and lung cancers.
Alimta, an innovative chemotherapy medicine for treating mesothelioma and non-small cell lung cancer.
Strattera, a non-stimulant medicine is a diverse treatment option for attention deficit hyperactivity disorder (ADHD).
Portrazza presents a major breakthrough in the treatment of metastatic squamous non-small cell lung cancer.